Starling Oncology, Inc. Impairment of Intangible Assets, Finite-lived
Starling Oncology, Inc. (DFPH) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-03-12
- Starling Oncology, Inc. impairment of intangible assets, finite-lived for fiscal 2025 was $0.00.
- Starling Oncology, Inc. impairment of intangible assets, finite-lived for fiscal 2024 was $0.00.
- Starling Oncology, Inc. impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
- Starling Oncology, Inc. impairment of intangible assets, finite-lived for fiscal 2022 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-12 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-26 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |